A Controlled Trial to Assess the Immunogenicity and Efficacy of Three Vaccine Dosing Strategies in HIV Infected Adults.
Phase of Trial: Phase III
Latest Information Update: 02 May 2017
At a glance
- Drugs GSK 1536489A (Primary) ; Influenza virus vaccines
- Indications Influenza A virus H1N1 subtype; Influenza A virus infections; Influenza virus infections
- Focus Pharmacodynamics
- 19 May 2016 Results of substudy assessing hemagglutination inhibition and microbead array assays published in the Vaccine.
- 20 Aug 2010 Actual initiation date changed from Apr 2009 to Oct 2008 as reported by ClinicalTrials.gov.
- 20 Aug 2010 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History